Procedure for export of pharmaceutical product | Technical documentation | DMF | CTD | eCTD | ACTD

Procedure for Export of Pharmaceutical Products

Overview of Drug Development Process

• The discussion begins with the introduction to the procedure for exporting pharmaceutical products, specifically focusing on B Pharmacy and Pharmaceutical Regulatory Science.

• Emphasis is placed on the development of new drugs, referred to as lead compounds or investigational products, which require preclinical trials to assess safety and efficacy.

Clinical Trials Phases

• After preclinical trials on animals, clinical trials are conducted on humans across multiple phases: Phase 0, Phase 1, Phase 2, Phase 3, and Phase 4.

• An application form called IND (Investigational New Drug Application) must be submitted to obtain permission for human trials after successful animal testing.

Approval Process for Market Launch

• Following successful clinical trials, data from both preclinical and clinical stages are compiled into a New Drug Application (NDA), which is then submitted to the FDA.

• The FDA reviews the NDA; if approved without issues, it allows the drug to be marketed. If there are deficiencies, approval may be delayed.

Generic Medicines and Their Approval

• Discussion shifts to generic medicines that emerge after patents expire (typically after 20 years), where companies can use existing formulas to create generics.

• For launching generic medicines in the market, an Abbreviated New Drug Application (ANDA) is required. This process also involves review by regulatory bodies like OGD (Office of Generic Drugs).

Regulatory Approval Process in Different Countries

• The regulatory approval process varies by country; in India, it involves CDSCO (Central Drugs Standard Control Organization), which reviews applications thoroughly before granting approval.

Focus on Export Procedures

• Transitioning into Unit Three's focus: procedures for exporting pharmaceutical products once they have been developed and approved.

• Key topics include understanding what documentation is necessary when exporting drugs such as syrups or tablets.

Technical Documentation Requirements

• A detailed study will cover various types of technical documentation required for drug export/import processes.

Importance of Drug Master File

• The concept of a Drug Master File is introduced; it contains comprehensive information about drug manufacturing processes including ingredients used and packaging details.

Content of Drug Master File

• The file includes critical information such as CMC (Chemistry Manufacturing Controls), non-CMC data, labeling details, excipients used in formulations among other essential properties related to drug production.

Clinical Trials and Drug Approval Process

Understanding the Application Process for Clinical Trials

• To initiate a clinical trial, one must fill out an application form known as the IND (Investigational New Drug Application), which requires attaching a Drug Master File (DMF) detailing the drug's pharmacological action, side effects, toxic effects, adverse effects, mechanism of action, onset of action, potency, and bioavailability.

• All relevant information regarding the drug must be included in the application; if not filled directly in the IND form, a separate DMF should be submitted to provide comprehensive details about the drug.

Transitioning from Clinical Trials to Market Launch

• After completing clinical trials, it is essential to submit another form called NDA (New Drug Application) to market the drug. This process involves compiling all results from various phases of clinical trials (Phase 0 through Phase 4).

• The DMF plays a crucial role in transitioning from non-clinical studies to clinical trials and ultimately launching into the market; it serves as a comprehensive record of all necessary data about the drug.

Key Documentation Formats: CTD and eCTD

• The Common Technical Document (CTD) is vital for submitting applications like IND or NDA. It standardizes documentation formats across different regulatory bodies.

• The CTD format includes structured sections similar to other application forms where personal details are required. This ensures consistency and clarity in submissions.

• Electronic Common Technical Document (eCTD) refers to submitting documents in PDF format electronically. This method became prevalent during lockdown periods for ease of submission without physical paperwork.

Importance of Proper Formatting in Applications

• Submitting applications using standardized formats like CTD or eCTD increases approval chances by making it easier for reviewers to assess completeness and accuracy.

• A well-prepared application reflects professionalism and thoroughness; thus, applicants should ensure that their submissions are meticulously organized according to established guidelines.

Export Procedures for Pharmaceutical Products

• Before exporting pharmaceutical products internationally, understanding licensing requirements and obtaining government approvals is critical for compliance with regulations governing export/import activities.

Understanding the Role of FDA and CDSCO in Drug Manufacturing and Export

Importance of Regulatory Approvals

• The FDA (Food and Drug Administration) and CDSCO (Central Drugs Standard Control Organization) play crucial roles in drug manufacturing, selling, and transitioning from pre-clinical to clinical phases.

• Approval from these regulatory bodies is essential for launching drugs into the market, including aspects like export and import processes.

• CDSCO regulates drug exports; without their approval, exporting a drug is not permissible.

Steps for Exporting Pharmaceuticals

Initial Requirements

• To begin exporting pharmaceuticals, one must first obtain an Import Export Code (IEC), which is necessary for international trade.

• A license and permit are also required before proceeding with any export activities.

Contacting Exporters

• It’s important to contact exporters in the destination country to facilitate the sale of your product abroad.

Product Registration

• Registering your product in the country where it will be exported is a critical step that ensures compliance with local regulations.

Finalizing Export Procedures

Obtaining Approvals

• After registration, obtaining approval from DCGI (Drug Controller General of India) is mandatory before proceeding with exports.

Shipping Method Selection

• Once all approvals are secured, finalize the shipping method—whether by air or sea—to transport your products effectively.

Documentation Process

Purchase Order Creation

• A purchase order outlines all items being sent, including quantities and prices. This document serves as a formal agreement between buyer and seller.

Commercial Invoice Preparation

• The commercial invoice is one of the most important documents in international trade. It acts as proof of sale between buyer and seller.

Contract Signing

Custom Clearance Process in Pharmaceutical Exports

Understanding Custom Clearance

• The speaker emphasizes the importance of signing a contract before initiating the custom clearance process, which is crucial for exporting pharmaceutical products.

• Custom clearance involves thorough checks to ensure that no illegal or substandard items are being sent across borders, confirming compliance with legal standards.

• If all items are verified as legal and compliant, they will be approved for export, allowing goods to cross into another country.

Requirements for Exporting Pharmaceuticals

• It is essential that drugs exported are not spurious, adulterated, or misbranded; they must meet quality standards and be registered in the destination country.

• The speaker suggests documenting terms and conditions related to drug exports upfront, including necessary licenses and permits required from authorities like CDSCO (Central Drugs Standard Control Organization).

Documentation Needed for Export

• Key documents include shipping documents that specify the mode of export (air or water), which is critical for tracking shipments.

• Three sets of documentation must be prepared: one for the Additional Drug Controller (ADC), one for the bank, and one for the buyer.

Principal Export Documents

• Essential principal export documents include commercial invoices detailing billing information and packing lists identifying contents within boxes using codes.

• A Bill of Lading is highlighted as a crucial document needed for international trade; it serves as proof of shipment and ownership during transit.

Additional Required Documents

• An Export Declaration Form (Form E), insurance certificates, and Certificates of Origin are necessary to validate where products were manufactured.

Documentation Required for Buyers

Key Documents for Buyers

• The buyer needs various documents including a commercial invoice, packaging list, Form E, certificate of analysis, certificate of origin, and a copy of the NOC.

• These documents are essential for regulatory compliance and facilitate the purchasing process.

Understanding Technical Documentation

• Technical documentation is straightforward; it involves listing all required documents that need to be memorized.

• The Drug Master File (DMF) contains comprehensive information about the drug's components such as excipients, binders, packaging details, labeling standards, preservatives used, stabilizing agents, colors, and flavoring agents.

Details in Drug Master File

Comprehensive Information in DMF

• The DMF includes preclinical trial data covering pharmacological actions, side effects, toxic effects, potency measures like Cmax and Tmax.

• It also holds confidential details regarding maximum tolerable doses and minimum effective concentrations.

CMC vs Non-CMC Information

• DMFs contain both Chemistry Manufacturing Control (CMC) information related to drug chemistry and manufacturing processes as well as non-CMC information concerning packaging and storage conditions.

Types of Drug Master Files

Submission Requirements

• A DMF must be submitted by pharmaceutical manufacturers to regulatory authorities when transitioning from preclinical to clinical phases or from clinical trials to market entry.

Types of DMFs Explained

Type 1: Plant Information

• Type 1 DMF provides detailed information about the manufacturing plant including site address and equipment capabilities.

Type 2: Drug Substance Information

• Type 2 DMF focuses on drug substance-related information including intermediates used in production.

Quality Control Measures

• Details on manufacturing procedures and controls are crucial for ensuring compliance with regulations aimed at preventing misuse.

Submission Process for Applications

Importance of Including DMF in Applications

Understanding DMF Types and Common Technical Document

Overview of DMF Types

• The discussion begins with an introduction to various types of Drug Master Files (DMFs), specifically focusing on Type 3, which pertains to packaging materials. It emphasizes the importance of understanding components and toxicological data related to these materials.

• Type 4 DMF is introduced, highlighting excipients related to drug substances, including coloring agents, flavoring agents, essences, and preservatives used in preparations.

• A summary of all DMF types is provided:

• Type 1: Plant information

• Type 2: Drug substance intermediate material details

• Type 3: Packaging materials

• Type 4: Excipients

• Type 5: Miscellaneous information not covered in previous types.

Introduction to Common Technical Document (CTD)

• The conversation shifts to the Common Technical Document (CTD), described as a standardized format for documentation required for regulatory submissions such as IND or NDA applications.

• CTD serves as a common framework for all application forms related to drug approval and marketing. This uniformity simplifies the submission process across different regulatory bodies.

• The CTD format is essential for ensuring that all applications submitted are consistent and meet international standards set by regulatory authorities like the FDA.

Specifications and International Acceptance

• CTD is defined as a set of specifications recognized internationally. It facilitates communication between manufacturers and regulatory agencies in regions like Europe, Japan, and the US.

• The significance of CTD lies in its role as an internationally accepted agreement format that streamlines documentation processes across various jurisdictions.

Historical Context of CTD Development

• In 2002, collaboration occurred between CTD developers and ICH (International Council for Harmonisation), leading to common guidelines aimed at standardizing drug application formats globally.

• By 2004, TGA (Therapeutic Goods Administration) adopted these common guidelines established through collaboration between CTD and ICH, further solidifying their importance in global pharmaceutical regulation.

Practical Implications of Using CTD Format

• Manufacturers benefit from using the CTD format when filling out application forms; it provides clarity on what information needs to be included without confusion or ambiguity.

• Utilizing a standardized format reduces time spent on submissions while ensuring compliance with regulatory requirements. This efficiency aids both manufacturers seeking approvals for clinical trials or generic drugs.

Required Paper Sizes for CTD Documentation

Differences in Paper Size Requirements

• In Europe and Japan, A4 size paper is required for Common Technical Document (CTD) documentation.

• In the United States, the required paper size is 8.5 x 11 inches, highlighting regional differences in documentation standards.

Importance of Margins in Notebooks

• When using spiral notebooks, it’s essential to leave a larger left-hand margin to prevent text from being cut off during binding.

• The left margin must be more significant than the right margin due to potential visibility issues caused by binding.

Font Specifications for CTD Documentation

• The recommended font is Times New Roman with a size of 12 points; page numbers should be included on every page.

• Consistency in font and formatting helps ensure clarity and ease of review for manufacturers submitting reports.

Overview of CTD Guidelines

Structure of CTD Documentation

• The CTD documentation must adhere to specific guidelines: A4 size in Europe/Japan and 8.5 x 11 inches in the US, with proper margins and font specifications.

Breakdown of Modules

• The technical document is completed in five modules:

• Module One: Regional Administration Information

• Module Two: Divided into seven parts covering various aspects like general introduction and quality overview.

Detailed Breakdown of Module Two

Components of Module Two

• Module Two consists of:

• 2.1: Table of Contents

• 2.2: General Introduction about formulation including physical/chemical properties.

• 2.3: Quality Overview related information.

Additional Parts within Module Two

• Following sections include:

• 2.4: Non-clinical Overview

• 2.5: Clinical Overview

• 2.6 & 2.7: Summaries related to non-clinical and clinical studies respectively.

Final Modules Overview

Summary of Remaining Modules

• Module Three focuses on quality-related information regarding products.

• Module Four contains complete information on non-clinical studies.

Overview of Electronic Common Technical Document (eCTD)

Introduction to Properties and Modules

• Discussion on physical and chemical properties of drugs, emphasizing the importance of not exceeding one property per drug.

• Overview of Module 4 containing non-clinical study reports and Module 5 for clinical study reports, highlighting their organization in the eCTD structure.

Understanding eCTD Format

• Explanation of XML (Extensible Markup Language) as a coding language used for encoding documents that are both human-readable and machine-readable.

• Clarification that eCTD submissions are made in PDF format, which is structured according to specific guidelines.

Submission Process

• Definition of eCTD as "Electronic Common Technical Document," indicating its electronic submission nature.

• Description of how documents are submitted sequentially in a structured manner following the eCTD guidelines.

Advantages of Using eCTD

• Emphasis on the ease of document management with PDFs, reducing physical storage issues and simplifying retrieval processes.

• Highlighting that regulatory authority burdens decrease due to simplified submission processes using PDF formats.

Structure and Modules in eCTD

• Breakdown of five modules within the eCTD: region-specific information, summary document, quality-related information, non-clinical study report, and clinical study report.

• Reminder to remember key components from previous discussions about quality aspects related to these modules.

Global Usage and Accessibility

• Mention that eCTDs are utilized across various countries including the US, Europe, Australia, Canada, South Africa, Japan, and Thailand.

• Benefits include easy access to information submitted in sequence via PDF format leading to streamlined review processes.

Conclusion on Efficiency Gains

Understanding ACTD and ASEAN Guidelines

Overview of ACTD

• The need for scanning and storing documents is eliminated, simplifying tracking and accessing information. This allows for quick access to the status of submissions (sent, in draft, etc.).

Definition of ACTD

• ACTD stands for ASEAN Common Technical Document. It is essential to understand its components, particularly the "A" which refers to the Association of Southeast Asian Nations (ASEAN).

ASEAN Background

• ASEAN was established in 1967 in Bangkok as a regulatory authority comprising ten countries. Its full form is the Association of Southeast Asian Nations.

Purpose of ACTD

• The guidelines provided by ASEAN serve as a format for preparing the Common Technical Document (CTD). Following these guidelines ensures that CTDs are well-structured and meet regulatory requirements.

Regulatory Authority's Role

• The ASEAN regulatory authority requires that any submitted CTDs adhere strictly to their guidelines. Approval will only be granted if submissions comply with these standards.

Importance of Compliance

• Submissions must follow specific formatting rules set by ASEAN to ensure clarity and transparency in data presentation. Properly formatted documents facilitate easier review and approval processes.

Submission Guidelines

• Key submission requirements include:

• Documents must be clear and transparent.

• Data should be presented without ambiguity.

• Proper spacing between text elements is crucial for readability.

Formatting Specifications

• Specific formatting details include:

• Use A4 paper size or 8.5 x 11 inches depending on the region.

• Maintain proper margins, especially on the left side due to potential binding issues.

• Font should be Times New Roman at size 12, with page numbers included on every page.

Benefits of Adhering to Guidelines

Pharmaceutical Biotechnology Product Variations

Understanding Major and Minor Variations

• Pharmaceutical biotechnology products can undergo major and minor variations even after approval. It is essential to fill out the appropriate forms for these changes.

• For any major variation in an already approved pharmaceutical product, a specific form must be completed in the CTD format to expedite approval.

• Minor variations also require formal approval, especially when registering generic drugs or launching new biotech products.

Components of the Common Technical Document (CTD)

• The CTD consists of several parts:

• Part 1 includes the Table of Contents, administrative data, and applicant information.

• Part 2 contains quality-related information about the product.

• Part 3 focuses on non-clinical documents including pharmacodynamic studies and safety pharmacology reports.

Clinical Documentation Submission

• Part 4 requires submission of clinical documents divided into six sections:

• A: Table of Contents

• B: Clinical Overview

• C: Clinical Summary

• D: Study Data

• E: Clinical Study Reports

• F: References

Importance of Proper Documentation

• Accurate completion of CTD components is crucial for successful drug registration and approval processes. Prioritization of documentation is emphasized for effective submissions.

Export Procedures for Pharmaceuticals

• When exporting drugs to other countries, it’s necessary to follow specific procedures including obtaining licenses, permits, approvals from regulatory bodies like DCGI, and ensuring all required codes are in place.

Understanding Anti-Platelet Effects

Question on Drug Effects

• A question regarding which drug possesses anti-platelet effects was discussed. Options included erythromycin (not an anti-platelet), desogestrel (not applicable), urokinase (does not prevent clotting), and clopidogrel (the correct answer).

Conclusion on Lecture Content

• Clopidogrel is identified as providing anti-platelet effects by preventing platelet aggregation. The lecture concludes with encouragement for further study through available resources.

Resources for Further Learning

Accessing Additional Materials